九典制药 - Financials

九典制药 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013
+Revenue	2.9B	2.7B	2.3B	1.6B	978.0M	924.0M	801.0M	535.0M	376.0M	290.0M	266.0M	241.0M
Revenue Growth %	8.8%	15.8%	42.9%	66.5%	5.8%	15.4%	49.7%	42.3%	29.7%	9.0%	10.4%	--
Total Revenue	2.9B	2.7B	2.3B	1.6B	978.0M	924.0M	801.0M	535.0M	376.0M	290.0M	266.0M	241.0M
Cost Of Revenue	784.0M	615.0M	517.0M	350.0M	246.0M	301.0M	324.0M	257.0M	183.0M	140.0M	128.0M	109.0M
+Gross Profit	2.1B	2.1B	1.8B	1.3B	732.0M	623.0M	477.0M	278.0M	193.0M	150.0M	138.0M	132.0M
Gross Margin %	73.3%	77.2%	77.8%	78.5%	74.8%	67.4%	59.6%	52.0%	51.3%	51.7%	51.9%	54.8%
Total Operating Cost	2.4B	2.3B	2.1B	1.4B	905.0M	875.0M	727.0M	463.0M	316.0M	245.0M	227.0M	217.0M
Selling Expenses	1.2B	1.3B	1.2B	832.0M	509.0M	409.0M	305.0M	142.0M	92.8M	61.2M	57.9M	58.1M
Admin Expenses	92.3M	98.0M	65.3M	46.2M	38.2M	35.7M	29.1M	26.2M	34.7M	39.6M	35.2M	45.7M
Rd Expenses	246.0M	254.0M	201.0M	146.0M	81.7M	110.0M	57.5M	28.6M	--	--	--	--
Finance Expenses	13.5M	6.0M	13.8M	13.3M	4.9M	4.2M	-636,400	178,100	1.3M	708,900	1.2M	2.3M
+Operating Income	575.0M	394.0M	291.0M	226.0M	91.7M	62.9M	80.2M	74.8M	60.8M	45.5M	40.4M	24.1M
Operating Margin %	19.6%	14.6%	12.5%	13.9%	9.4%	6.8%	10.0%	14.0%	16.2%	15.7%	15.2%	10.0%
Non Operating Income	1.6M	10.4M	1.0M	2.5M	789,100	828,700	628,900	3.5M	2.7M	5.6M	3.9M	5.9M
Non Operating Expenses	4.4M	2.6M	2.1M	2.2M	1.7M	4.8M	1.5M	1.3M	825,300	1.5M	705,200	1.1M
Investment Income	3.1M	2.1M	1.8M	2.9M	--	--	853,900	--	--	-52,800	852,600	10,500
Asset Disposal Income	--	30,300	--	16,000	--	-116,400	123,100	--	--	--	--	--
Asset Impairment Loss	6.5M	6.6M	5.5M	15.6M	7.3M	1.9M	2.3M	2.7M	-211,900	554,100	2.1M	606,100
Other Income	52.4M	29.1M	25.3M	25.1M	18.4M	14.0M	5.1M	3.3M	--	--	--	--
Income Before Tax	572.0M	402.0M	290.0M	226.0M	90.8M	58.9M	79.4M	77.0M	62.7M	49.5M	43.6M	29.0M
Income Tax	59.8M	33.9M	20.5M	21.9M	8.6M	3.8M	7.4M	8.4M	8.1M	4.9M	5.8M	3.7M
+Net Income	512.0M	368.0M	270.0M	204.0M	82.3M	55.1M	72.0M	68.6M	54.5M	44.6M	37.8M	25.3M
Net Margin %	17.5%	13.7%	11.6%	12.5%	8.4%	6.0%	9.0%	12.8%	14.5%	15.4%	14.2%	10.5%
Net Income Attributable	512.0M	368.0M	270.0M	204.0M	82.3M	55.1M	72.0M	68.6M	54.5M	44.6M	37.8M	25.3M
Minority Interest	--	--	--	--	--	--	--	--	--	--	-5,900	-1,200
Eps Basic	1.05	0.77	0.82	0.62	0.35	0.23	0.31	0.36	0.63	0.55	0.80	0.61
Eps Diluted	1.04	0.73	0.82	0.62	0.35	0.23	0.31	0.36	0.63	0.55	0.80	0.61

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013
Cash And Equivalents	443.0M	425.0M	346.0M	398.0M	135.0M	132.0M	171.0M	298.0M	70.8M	34.0M	27.8M	43.0M
Trading Financial Assets	261.0M	90.3M	90.3M	100.0M	--	--	--	--	--	--	--	--
Accounts Receivable	351.0M	546.0M	458.0M	249.0M	164.0M	131.0M	112.0M	81.8M	52.1M	45.0M	31.5M	34.2M
Notes Receivable	49.5M	32.3M	21.4M	13.6M	14.4M	17.2M	42.7M	37.5M	22.8M	20.6M	19.9M	8.8M
Notes And Accounts Receivable	400.0M	578.0M	480.0M	262.0M	179.0M	148.0M	154.0M	119.0M	74.9M	65.6M	51.3M	43.0M
Prepayments	36.6M	13.0M	20.0M	6.6M	6.0M	2.8M	7.6M	1.9M	5.4M	4.0M	6.3M	1.6M
Inventory	368.0M	266.0M	241.0M	214.0M	153.0M	136.0M	109.0M	95.9M	77.6M	63.9M	55.5M	52.4M
Total Current Assets	1.6B	1.4B	1.2B	1.0B	504.0M	454.0M	466.0M	519.0M	235.0M	181.0M	146.0M	145.0M
Long Term Equity Investment	33.4M	--	--	--	--	--	--	--	--	--	--	--
Fixed Assets	--	1.1B	584.0M	589.0M	508.0M	534.0M	351.0M	131.0M	112.0M	90.9M	86.6M	76.3M
Fixed Assets Total	1.3B	1.1B	584.0M	589.0M	508.0M	534.0M	351.0M	131.0M	112.0M	90.9M	86.6M	76.3M
Construction In Progress	--	69.3M	308.0M	18.2M	24.9M	2.1M	53.8M	42.9M	25.7M	21.5M	10.6M	4.1M
Construction In Progress Total	81.0M	69.3M	308.0M	18.2M	24.9M	2.1M	53.8M	42.9M	25.7M	21.5M	10.6M	4.1M
Intangible Assets	112.0M	88.8M	91.7M	77.4M	51.1M	52.1M	52.9M	52.0M	17.4M	19.7M	21.6M	24.0M
Long Term Deferred Expenses	4.2M	4.3M	2.1M	3.2M	2.8M	3.4M	400,500	604,300	649,800	746,500	1.3M	1.6M
Total Non Current Assets	1.8B	1.4B	1.1B	725.0M	627.0M	618.0M	477.0M	251.0M	162.0M	137.0M	123.0M	108.0M
Total Assets	3.4B	2.9B	2.3B	1.7B	1.1B	1.1B	943.0M	769.0M	397.0M	318.0M	269.0M	252.0M
Short Term Borrowings	--	51.8M	71.6M	53.8M	10.4M	65.0M	50.0M	4.0M	20.0M	20.0M	15.0M	30.0M
Accounts Payable	126.0M	136.0M	106.0M	86.4M	50.6M	65.0M	54.7M	32.6M	30.2M	23.7M	20.2M	15.6M
Advance Receipts	--	--	--	--	--	16.5M	16.0M	12.0M	7.7M	7.1M	6.1M	10.6M
Contract Liabilities	30.4M	37.3M	72.2M	57.4M	42.2M	--	--	--	--	--	--	--
Total Current Liabilities	392.0M	416.0M	444.0M	370.0M	181.0M	201.0M	157.0M	80.0M	72.2M	62.0M	56.8M	73.2M
Long Term Borrowings	128.0M	58.8M	231.0M	21.1M	70.5M	68.7M	29.7M	--	--	--	--	--
Total Non Current Liabilities	455.0M	482.0M	303.0M	276.0M	114.0M	110.0M	67.9M	29.0M	1.4M	1.8M	1.9M	3.1M
Total Liabilities	846.0M	898.0M	747.0M	646.0M	295.0M	310.0M	225.0M	109.0M	73.6M	63.8M	58.7M	76.3M
Paid In Capital	496.0M	345.0M	343.0M	235.0M	235.0M	235.0M	235.0M	117.0M	88.0M	80.6M	47.4M	47.4M
Capital Reserve	564.0M	530.0M	485.0M	279.0M	279.0M	279.0M	279.0M	396.0M	157.0M	138.0M	38.8M	38.8M
Surplus Reserve	166.0M	124.0M	91.5M	65.2M	43.3M	34.6M	28.1M	19.7M	13.0M	7.8M	14.2M	10.4M
Retained Earnings	1.2B	888.0M	633.0M	451.0M	279.0M	214.0M	177.0M	127.0M	65.2M	28.2M	109.0M	79.3M
Minority Equity	--	--	--	--	--	--	--	--	--	--	--	-88,900
Equity Attributable	2.5B	2.0B	1.6B	1.1B	836.0M	762.0M	718.0M	660.0M	323.0M	255.0M	210.0M	176.0M
Total Equity	2.5B	2.0B	1.6B	1.1B	836.0M	762.0M	718.0M	660.0M	323.0M	255.0M	210.0M	176.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013
Cash From Sales	3.5B	2.9B	2.4B	1.8B	1.1B	1.1B	897.0M	581.0M	428.0M	324.0M	298.0M	279.0M
Tax Refunds Received	2.3M	435,700	10.6M	2.6M	1.3M	--	--	--	--	--	--	241,800
Total Operating Cash Inflow	3.6B	3.1B	2.5B	1.8B	1.1B	1.1B	915.0M	620.0M	431.0M	330.0M	301.0M	281.0M
Cash Paid For Goods	794.0M	521.0M	493.0M	309.0M	241.0M	346.0M	377.0M	308.0M	209.0M	153.0M	145.0M	133.0M
Cash Paid To Employees	349.0M	281.0M	228.0M	184.0M	125.0M	103.0M	75.1M	52.3M	47.2M	44.2M	35.6M	30.5M
Taxes Paid	307.0M	303.0M	254.0M	191.0M	106.0M	98.8M	87.2M	49.3M	37.2M	34.2M	33.6M	30.1M
Total Operating Cash Outflow	2.8B	2.6B	2.3B	1.6B	975.0M	986.0M	847.0M	539.0M	376.0M	297.0M	271.0M	250.0M
Operating Cash Flow	746.0M	431.0M	269.0M	191.0M	150.0M	90.7M	68.2M	80.4M	55.2M	32.2M	30.1M	30.6M
Total Investing Cash Inflow	534.0M	182.0M	342.0M	283.0M	46,800	3.1M	151.0M	--	--	195,400	411,800	3.1M
Total Investing Cash Outflow	1.2B	607.0M	773.0M	512.0M	78.4M	182.0M	407.0M	97.8M	31.4M	30.4M	26.5M	59.8M
Investing Cash Flow	-652.0M	-425.0M	-431.0M	-230.0M	-78.3M	-179.0M	-256.0M	-97.8M	-31.4M	-30.2M	-26.1M	-56.7M
Cash From Borrowings	81.4M	158.0M	315.0M	53.7M	19.9M	115.0M	120.0M	15.0M	20.0M	20.0M	15.0M	30.0M
Dividends And Interest Paid	116.0M	94.6M	69.3M	15.0M	13.8M	15.5M	15.5M	676,700	13.6M	922,900	5.0M	2.1M
Debt Repayments	61.2M	364.0M	124.0M	17.7M	71.6M	54.5M	44.0M	31.0M	20.0M	15.0M	30.0M	20.0M
Total Financing Cash Inflow	101.0M	539.0M	315.0M	324.0M	19.9M	115.0M	121.0M	284.0M	47.7M	20.0M	16.0M	78.3M
Total Financing Cash Outflow	177.0M	465.0M	194.0M	40.1M	85.4M	70.0M	60.5M	41.3M	34.6M	15.9M	35.2M	22.2M
Financing Cash Flow	-76.5M	73.6M	121.0M	284.0M	-65.5M	45.0M	60.2M	243.0M	13.1M	4.1M	-19.2M	56.1M
Net Change In Cash	18.3M	80.2M	-41.3M	245.0M	6.2M	-43.2M	-128.0M	226.0M	36.8M	6.1M	-15.1M	29.9M
Ending Cash Balance	434.0M	415.0M	335.0M	376.0M	132.0M	125.0M	169.0M	296.0M	70.8M	34.0M	27.8M	43.0M
Capex	398.0M	427.0M	413.0M	126.0M	78.4M	182.0M	257.0M	97.8M	31.4M	29.6M	26.5M	54.0M